Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells

Journal of Molecular Endocrinology

Volumn 49, Issue 3, 2012, Pages 203-211

  Raichur, Suryaprakash ^a   Teh, Song Hooi ^a   Ohwaki, Kenji ^a   Gaur, Vidhi ^b   Long, Yun Chau ^c   Hargreaves, Mark ^d   McGee, Sean L ^b   Kusunoki, Jun ^a  

^a Eli Lilly Singapore Pte Ltd   (Singapore)

^b DEAKIN UNIVERSITY   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; HISTONE DEACETYLASE 5; HISTONE H3; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; GENE SILENCING; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MUSCLE CELL; MUSCLE METABOLISM; MYOTUBE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; GLUCOSE; HISTONE DEACETYLASES; HUMANS; INSULIN; MUSCLE CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84867909223     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0095     Document Type: Article

References (27)

1. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW III, Kang L, Rabinovitch PS, Szeto HH et al. 2009 Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. Journal of Clinical Investigation 119 573-581. (doi:10.1172/JCI37048)
2. Bradner JE, West N, Grachan ML, Greenberg EF, Haggarty SJ, Warnow T & Mazitschek R 2010 Chemical phylogenetics of histone deacetylase inhibitors. Nature Chemical Biology 6 238-243. (doi:10.1038/nchembio.313)
3. Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JA & Olson EN 2004 Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Molecular and Cellular Biology 24 8467-8476. (doi:10.1128/MCB.24.19.8467-8476.2004)
4. Chang S, Young BD, Li S, Qi X, Richardson JA & Olson EN 2006 Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126 321-334. (doi:10.1016/j.cell. 2006.05.040)
5. Czubryt MP, McAnally J, Fishman GI & Olson EN 2003 Regulation of peroxisome proliferator-activated receptor g coactivator 1a (PGC-1a) and mitochondrial function by MEF2 and HDAC5. PNAS 100 1711-1716. (doi:10.1073/pnas.0337639100)
6. Dai YS, Xu J & Molkentin JD 2005 The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Molecular and Cellular Biology 25 9936-9948. (doi:10.1128/MCB.25.22.9936-9948.2005)
7. Deng X, Ewton DZ, Mercer SE & Friedman E 2005 Mirk/dyrk1B decrease the nuclear accumulation of class IIa histone deacetylases during skeletal muscle differentiation. Journal of Biological Chemistry 280 4894-4905. (doi:10.1074/jbc.M411894200)
8. Dressel U, Bailey PJ, Wang SC, DownesM, Evans RM& Muscat GE 2001 A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. Journal of Biological Chemistry 276 17007-17013. (doi:10.1074/jbc.M101508200)
9. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, VoelterW& Verdin E 2002 Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Molecular Cell 9 45-57. (doi:10.1016/ S1097-2765(01)00429-4)
10. Franko A, Mayer S, Thiel G, Mercy L, Arnould T, Hornig-Do HT, Wiesner RJ & Goffart S 2008 CREB-1a is recruited to and mediates upregulation of the cytochrome c promoter during enhanced mitochondrial biogenesis accompanying skeletal muscle differentiation. Molecular and Cellular Biology 28 2446-2459. (doi:10.1128/ MCB.00980-07)
11. Kahn BB, Alquier T, Carling D & Hardie DG 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 1 15-25. (doi:10.1016/j.cmet.2004.12.003)
12. Li B, Carey M & Workman JL 2007 The role of chromatin during transcription. Cell 128 707-719. (doi:10.1016/j.cell.2007.01.015)
13. Lin JD 2009 Minireview: the PGC-1 coactivator networks: chromatinremodeling and mitochondrial energy metabolism. Molecular Endocrinology 23 2-10. (doi:10.1210/me.2008-0344)
14. Lu J, McKinsey TA, Zhang CL & Olson EN 2000 Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Molecular Cell 6 233-244. (doi:10.1016/ S1097-2765(00)00025-3)
15. McGee SL & Hargreaves M 2010 AMPK-mediated regulation of transcription in skeletal muscle. Clinical Science 118 507-518. (doi:10.1042/CS20090533)
16. McGee SL, van Denderen BJ, Howlett KF, Mollica J, Schertzer JD, Kemp BE & Hargreaves M 2008 AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57 860-867. (doi:10.2337/db07-0843)
17. McKinsey TA, Zhang CL, Lu J & Olson EN 2000 Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408 106-111. (doi:10.1038/35040593)
18. McKinsey TA, Zhang CL & Olson EN 2001 Control of muscle development by dueling HATs and HDACs. Current Opinion in Genetics & Development 11 497-504. (doi:10.1016/S0959-437X(00) 00224-0)
19. Micheli L, Leonardi L, Conti F, Buanne P, Canu N, Caruso M & Tirone F 2005 PC4 coactivates MyoD by relieving the histone deacetylase 4 mediated inhibition of myocyte enhancer factor 2C. Molecular and Cellular Biology 25 2242-2259. (doi:10.1128/MCB.25. 6.2242-2259.2005)
20. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, Downes M, Evan RM, Montminy M & Shaw RJ 2011 Class IIa histone deacetylases are regulators of FOXO and mammalian glucose homeostasis. Cell 145 607-621. (doi:10.1016/j.cell.2011.03.043)
21. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, Richardson JA, Bassel-Duby R & Olson EN 2007 Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. Journal of Clinical Investigation 117 2459-2467. (doi:10.1172/JCI31960)
22. Savage DB, Petersen KF & Shulman GI 2007 Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiological Reviews 87 507-520. (doi:10.1152/physrev.00024.2006)
23. Takigawa-Imamura H, Sekine T, Murata M, Takayama K, Nakazawa K & Nakagawa J 2003 Stimulation of glucose uptake in muscle cells by prolonged treatment with scriptide, a histone deacetylase inhibitor. Bioscience, Biotechnology, and Biochemistry 67 1499-1506. (doi:10. 1271/bbb.67.1499)
24. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, PomajzlC, Shelton JM, Richardson JA et al. 2004 Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119 555-566. (doi:10.1016/j.cell.2004.10.024)
25. Xing W, Zhang TC, Cao D, Wang Z, Antos CL, Li S, Wang Y, Olsen EN & Wang DZ 2006 Myocardin induces cardiomyocyte hypertrophy. Circulation Research 98 1089-1097. (doi:10.1161/01.RES. 0000218781.23144.3e)
26. Zhang CL, McKinsey TA & Olsen EN 2001 The transcriptional corepressor MITR is a signal responsive inhibitor of myogenesis. PNAS 98 7354-7359. (doi:10.1073/pnas.131198498)
27. Zhang CL, McKinsey TA & Olson EN 2002 Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Molecular and Cellular Biology 22 7302-7312. (doi:10.1128/MCB.22. 20.7302-7312.2002)